Global drugmakers in no hurry to leave Russian market

11 May 2023
russia_flag_sky_big

Global drugmakers are in no hurry to leave the Russian market, still considering the local market as one of the most promising for their growth, according to recent statements made by Mikhail Murashko, head of the Russian Ministry of Health.

According to him, despite sanctions and the ever-growing isolation of the country in the international arena, in Russia in recent years, new production of medicines has been launched almost every month including those with the participation of foreigners.

Mr Murashko commented: "Foreign suppliers of drugs are in no hurry to leave the market. I must say that for them this is a significant volume of sales, and the market with the capacity of our country is a fairly a decent market for them.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical